Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BKNG vs GSK✓SelectedUSD · GSKBKNG vs GSK performance historyLatest closeAs of-1.64%11/20
Stock and ETF performance explorer

BKNG vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+61.4%
GSK return
+40.7%
Excess return
+20.8%
Maximum drawdown
-39.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.6%-0.1%-1.5%-1.6%
7D-9.2%-5.3%-3.9%-8.0%
30D-8.5%-3.7%-4.8%-7.7%
3M-30.8%-7.3%-23.5%-29.6%
6M-7.2%-4.2%-3.0%-6.3%
YTD-31.9%+0.9%-32.7%-32.3%
1Y-20.2%+7.3%-27.5%-21.8%
3Y+17.4%+52.7%-35.3%+1.8%
All+61.4%+40.7%+20.8%+22.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling